drugset

drugset / Trial / NCT00946790

To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

NCT00946790 ↗

Phase 1 Completed 72 enrolled Sandoz

RandomizedCrossoverOpen-labelTreatment

Summary

To demonstrate the relative bioavailability of hydroxychloroquine sulfate, 200 mg tablets.

Timeline

Start: 1993-07
Primary completion: 1993-12
Completion: 1993-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Hydroxychloroquine	Small molecule	200 mg	—

Indications